A randomised, double-blind, placebo-controlled, flexible-dose, parallel-group study to evaluate the efficacy, safety and toleration of oral sildenafil citrate administered in the dose range of 20-80 Mg TID [three times daily] for the treatment of pre-eclampsia (PET)

Trial Profile

A randomised, double-blind, placebo-controlled, flexible-dose, parallel-group study to evaluate the efficacy, safety and toleration of oral sildenafil citrate administered in the dose range of 20-80 Mg TID [three times daily] for the treatment of pre-eclampsia (PET)

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2009

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Preeclampsia; Pregnancy; Preterm birth
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Nov 2009 Results published in Hypertension in Pregnancy.
    • 08 Jun 2007 Status changed from in progress to discontinued.
    • 02 Feb 2007 Status change from recruiting to in progress
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top